PL-SIN-PGK-EGFP Citations (3)

Originally described in: Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency.
Hotta A, Cheung AY, Farra N, Vijayaragavan K, Seguin CA, Draper JS, Pasceri P, Maksakova IA, Mager DL, Rossant J, Bhatia M, Ellis J Nat Methods. 2009 May . 6(5):370-6. PubMed Journal

---

Articles Citing PL-SIN-PGK-EGFP

Articles
FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy. Quintanal-Villalonga A, Ferrer I, Guruceaga E, Cirauqui C, Marrugal A, Ojeda L, Garcia S, Zugazagoitia J, Munoz-Galvan S, Lopez-Rios F, Montuenga L, Vicent S, Molina-Pinelo S, Carnero A, Paz-Ares L. EBioMedicine. 2020 Mar;53:102683. doi: 10.1016/j.ebiom.2020.102683. Epub 2020 Feb 27. PubMed
RP105 plays a cardioprotective role in myocardial ischemia reperfusion injury by regulating the Tolllike receptor 2/4 signaling pathways. Huang W, Yang J, He C, Yang J. Mol Med Rep. 2020 Aug;22(2):1373-1381. doi: 10.3892/mmr.2020.11242. Epub 2020 Jun 16. PubMed
Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses. Schulz R, Korkut-Demirbas M, Venturino A, Colombo G, Siegert S. Nat Commun. 2022 Aug 15;13(1):4728. doi: 10.1038/s41467-022-32390-1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.